Ignite Creation Date:
2024-10-26 @ 3:38 PM
Last Modification Date:
2024-10-26 @ 3:38 PM
Study NCT ID:
NCT06561178
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-08-12
Brief Title:
Individualized Tumor-Informed CtDNA Analysis for Monitoring Postoperative Recurrence in ESCC NEOCRTEC2401
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Individualized Tumor-Informed Circulating Tumor DNA ctDNA Analysis for Monitoring Postoperative Recurrence Following Neoadjuvant Therapy in Esophageal Squamous Cell Carcinoma NEOCRTEC2401
Status:
RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of this observational study or is to explore the correlation between dynamic changes in postoperative circulating tumor DNA ctDNA and recurrence risk using a novel tumor-informed ctDNA detection technique thus laying the foundation for further promoting ctDNA detection to guide postoperative adjuvant therapy decisions This study focuses on patients with esophageal squamous cell carcinoma who did not achieve pCR following neoadjuvant therapy combined with surgical resection The main question it aims to answer is
Is there a correlation between postoperative ctDNA changes and tumor recurrence
Participants will be asked to undergo postoperative ctDNA detection
Is there a correlation between postoperative ctDNA changes and tumor recurrence
Participants will be asked to undergo postoperative ctDNA detection
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None